Cite Filings / ELOX / 0001193125-26-214720
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
DEF 14C

Filing

Eloxx Pharmaceuticals, Inc. · Filed 2026-05-08 · Acc 0001193125-26-214720

Documents 1

  • DEF 14C , d125964ddef14c.htm

Around this filing

  • 2026-05-08 4 Director acquired 1,875 shares (option exercise)
  • 2026-05-08 4 President and CEO acquired 472,826 shares (option exercise)
  • 2026-05-08 4 Director acquired 1,875 shares (option exercise)
  • 2026-05-08 DEF 14C DEF 14C
  • 2026-05-07 S-1 Registration Statement
  • 2026-05-05 10-Q Quarterly Report
  • 2018-03-30 DEF 14C DEF 14C

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading d125964ddef14c.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…